This message contains My NCBI what's new results from the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).
Do not reply directly to this message.

Sender's message: Search: MULTIPLE SCLEROSIS

1:	Patel PN.
	Low-Dose Naltrexone for Treatment of Multiple Sclerosis: Clinical Trials Are Needed (September). Ann Pharmacother. 2007 Jul 10; [Epub ahead of print] No abstract available. PMID: 17623758 [PubMed - as supplied by publisher]

2:	Marrosu F, Maleci A, Cocco E, Puligheddu M, Barberini L, Marrosu MG.
	Vagal nerve stimulation improves cerebellar tremor and dysphagia in multiple sclerosis. Mult Scler. 2007 Jul 10; [Epub ahead of print] PMID: 17623740 [PubMed - as supplied by publisher]

3:	Holley JE, Newcombe J, Winyard PG, Gutowski NJ.
	Peroxiredoxin V in multiple sclerosis lesions: predominant expression by astrocytes. Mult Scler. 2007 Jul 10; [Epub ahead of print] PMID: 17623739 [PubMed - as supplied by publisher]

4:	Kos D, D'Hooghe MB, Nagels G, Duportail M, Kerckhofs E.
	Multidisciplinary fatigue management programme in multiple sclerosis: a randomized clinical trial. Mult Scler. 2007 Jul 10; [Epub ahead of print] PMID: 17623738 [PubMed - as supplied by publisher]

5:	Jeffery DR.
	Failure of allogeneic bone marrow transplantation to arrest disease activity in multiple sclerosis. Mult Scler. 2007 Jul 10; [Epub ahead of print] PMID: 17623737 [PubMed - as supplied by publisher]

6:	Pohlau D, Przuntek H, Sailer M, Bethke F, Koehler J, Konig N, Heesen C, Spath P, Andresen I.
	Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study. Mult Scler. 2007 Jul 10; [Epub ahead of print] PMID: 17623736 [PubMed - as supplied by publisher]

7:	Glanz BI, Holland CM, Gauthier SA, Amunwa EL, Liptak Z, Houtchens MK, Sperling RA, Khoury SA, Guttmann CR, Weiner H.
	Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis. Mult Scler. 2007 Jul 10; [Epub ahead of print] PMID: 17623735 [PubMed - as supplied by publisher]

8:	Debouverie M, Pittion-Vouyovitch S, Louis S, Roederer T, Guillemin F.
	Increasing incidence of multiple sclerosis among women in Lorraine, Eastern France. Mult Scler. 2007 Jul 10; [Epub ahead of print] PMID: 17623734 [PubMed - as supplied by publisher]

9:	Ann Marrie R, Goldman M.
	Validity of performance scales for disability assessment in multiple sclerosis. Mult Scler. 2007 Jul 10; [Epub ahead of print] PMID: 17623733 [PubMed - as supplied by publisher]

10:	Cetin K, Johnson KL, Ehde DM, Kuehn CM, Amtmann D, Kraft GH.
	Antidepressant use in multiple sclerosis: epidemiologic study of a large community sample. Mult Scler. 2007 Jul 10; [Epub ahead of print] PMID: 17623732 [PubMed - as supplied by publisher]

11:	Tripoliti E, Campbell C, Pring TR, Taylor-Goh S.
	Quality of life in multiple sclerosis: should clinicians trust proxy ratings? Mult Scler. 2007 Jul 10; [Epub ahead of print] PMID: 17623731 [PubMed - as supplied by publisher]

12:	Younes M, Hill J, Quinless J, Kilduff M, Peng B, Cook SD, Cadavid D.
	Internet-based cognitive testing in multiple sclerosis. Mult Scler. 2007 Jul 10; [Epub ahead of print] PMID: 17623730 [PubMed - as supplied by publisher]

13:	Sobocki P, Pugliatti M, Lauer L, Kobelt G.
	Estimation of the cost of MS in Europe: Extrapolations from a multinational cost study. Mult Scler. 2007 Jul 10; [Epub ahead of print] PMID: 17623729 [PubMed - as supplied by publisher]

14:	Solari A, Motta A, Radice D, Mendozzi L.
	A shortened version of PASAT-3 is feasible. Mult Scler. 2007 Jul 10; [Epub ahead of print] PMID: 17623728 [PubMed - as supplied by publisher]

15:	Sweetland J, Riazi A, Cano SJ, Playford ED.
	Vocational rehabilitation services for people with multiple sclerosis: what patients want from clinicians and employers. Mult Scler. 2007 Jul 10; [Epub ahead of print] PMID: 17623726 [PubMed - as supplied by publisher]

16:	de Las Heras V, de Andres C, Tellez N, Tintore M.
	Pregnancy in multiple sclerosis patients treated with immunomodulators prior to or during part of the pregnancy: a descriptive study in the Spanish population. Mult Scler. 2007 Jul 10; [Epub ahead of print] PMID: 17623725 [PubMed - as supplied by publisher]

17:	Kotini A, Anninos P, Tamiolakis D, Prassopoulos P.
	Differentiation of meg activity in multiple sclerosis patients with the use of nonlinear analysis. J Integr Neurosci. 2007 Jun;6(2):233-40. PMID: 17622980 [PubMed - in process]

18:	Grossman I, Avidan N, Singer C, Goldstaub D, Hayardeny L, Eyal E, Ben-Asher E, Paperna T, Pe'er I, Lancet D, Beckmann JS, Miller A.
	Pharmacogenetics of glatiramer acetate therapy for multiple sclerosis reveals drug-response markers. Pharmacogenet Genomics. 2007 Aug;17(8):657-666. PMID: 17622942 [PubMed - as supplied by publisher]

19:	McQuillin A, Rizig M, Gurling HM.
	A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of bipolar affective disorder. Pharmacogenet Genomics. 2007 Aug;17(8):605-17. PMID: 17622937 [PubMed - in process]

20:	Johnson KP.
	Natalizumab (tysabri) treatment for relapsing multiple sclerosis. Neurologist. 2007 Jul;13(4):182-7. PMID: 17622909 [PubMed - in process]